EUVIMEDEUVIMED entdecken
Open Access

Stromal CD163-positive Macrophage Enrichment Is Associated With a FOXP3-skewed Immune Profile and Poor Prognosis in Esophageal Squamous Cell Carcinoma

Wenpeng Jiao, Fei Lv, Xudi Liu, Dan Wang, Jia Han, Sohsuke Yamada, Yao Liu

Cancer Genomics - Proteomics · 2026-11 · 23 (6) · 1192-1207

DOI: 10.21873/cgp.20624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 31.10.2026. Verfasst von Wenpeng Jiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa, Japan. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Macrophages. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Transcription FactorsEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsMacrophagesAntigens, CDReceptors, Cell SurfaceAntigens, Differentiation, MyelomonocyticHumansFemaleMalePrognosisMiddle AgedCD163 AntigenAgedTumor Microenvironment

Stichwörter der Autor:innen

CD163-positive macrophagesEsophageal squamous cell carcinoma (ESCC)prognosisstromal immune architecturetumor microenvironment

Substanzen

Forkhead Transcription FactorsFOXP3 protein, humanAntigens, CDReceptors, Cell SurfaceCD163 AntigenAntigens, Differentiation, Myelomonocytic

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa, Japan.
  • Department of Pathology, Kanazawa Medical University Hospital, Ishikawa, Japan.
  • Department of Chest Radiotherapy I, The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
  • Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
  • Department of Pathology, The People's Hospital of Kaizhou District, Chongqing, P.R. China.
  • Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa, Japan; sohsuke@kanazawa-med.ac.jp liuyao5139@163.com.

Zitieren

APA

Jiao, W., Lv, F., Liu, X., Wang, D., Han, J., Yamada, S., & Liu, Y. (2026). Stromal CD163-positive Macrophage Enrichment Is Associated With a FOXP3-skewed Immune Profile and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Genomics - Proteomics, 23(6), 1192-1207. https://doi.org/10.21873/cgp.20624

Vancouver

Jiao W, Lv F, Liu X, Wang D, Han J, Yamada S, et al. Stromal CD163-positive Macrophage Enrichment Is Associated With a FOXP3-skewed Immune Profile and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Genomics - Proteomics. 2026;23(6):1192-1207. doi:10.21873/cgp.20624

BibTeX
@article{Jiao2026,
  author = {Jiao, Wenpeng and Lv, Fei and Liu, Xudi and Wang, Dan and Han, Jia and Yamada, Sohsuke and Liu, Yao},
  title = {Stromal CD163-positive Macrophage Enrichment Is Associated With a FOXP3-skewed Immune Profile and Poor Prognosis in Esophageal Squamous Cell Carcinoma},
  journal = {Cancer Genomics - Proteomics},
  year = {2026},
  volume = {23},
  number = {6},
  pages = {1192--1207},
  doi = {10.21873/cgp.20624}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche